Indication
Treatment of invasive candidiasis in adults and paediatric patients aged 1 month to < 18 years.
Loading your page…
Loading your page…
Candidiasis
Marketing Authorisation Holder: Pfizer Europe MA EEIG
EMA Authorisation: 20/09/2007
INN: anidulafungin
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ecalta: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.